Quick verdict: ACLS vs CNXC in 2026

In this comprehensive ACLS vs CNXC stock comparison for 2026, Concentrix Corporation (CNXC) emerges with a strong overall edge, leading Axcelis Technologies, Inc. (ACLS) in several key areas. CNXC presents a compelling case for growth and value investors, demonstrating positive revenue growth, significantly lower valuation multiples, and robust analyst confidence. Conversely, ACLS stands out for its superior current profitability and stronger balance sheet, but faces challenges with negative revenue growth and a high valuation relative to its current fundamentals. Not investment advice.

ACLS vs CNXC: key metrics side by side

Full side-by-side comparison of ACLS and CNXC across valuation, profitability, growth and analyst sentiment. Data updated 2026-05-08.

ACLS vs CNXC valuation comparison

When conducting an ACLS vs CNXC valuation assessment, the differences are stark. Axcelis Technologies (ACLS) currently trades at a P/E ratio of 48.32x, indicating a premium valuation compared to its current earnings. Its Price-to-Book ratio stands at 4.67x, also suggesting the market values its assets at a significant premium. The discounted cash flow (DCF) model for ACLS estimates a fair value of $61.76, implying a substantial downside of -61.1% from its current price of $158.66. This suggests that ACLS’s current market price might be well above its intrinsic value based on future cash flow projections.

In contrast, Concentrix Corporation (CNXC) presents a dramatically different picture in terms of valuation. CNXC has a negative P/E ratio of -1.18x, which stems from its current unprofitability (negative net margin of -13.34%). However, its Price-to-Book ratio is a very low 0.56x, suggesting the stock is trading below its book value, often a sign of deep value or market skepticism regarding future prospects. The DCF model for CNXC, despite its current losses, forecasts a fair value of $353.23, representing an astounding upside of +1287.4% from its current price of $25.46. This huge discrepancy between current price and DCF suggests that the market may be heavily discounting CNXC’s future earnings potential, or that the DCF model assumes a strong turnaround in profitability.

ACLS vs CNXC growth comparison

Examining the ACLS vs CNXC growth profiles reveals divergent trajectories. Axcelis Technologies (ACLS) reported a year-over-year revenue growth of -17.6%, indicating a contraction in its top line. This negative growth, coupled with a relatively high market capitalization of $4.88B and a high P/E ratio, may concern growth-focused investors who look for consistent expansion. While ACLS maintains healthy gross and net margins, the current decline in revenue momentum suggests potential headwinds or a cyclical downturn in its industry.

Conversely, Concentrix Corporation (CNXC), despite its much larger revenue base of $9.83B, managed to achieve a positive revenue growth of +2.2% year-over-year. This modest but positive growth, especially when compared to ACLS’s negative growth, suggests that CNXC has stronger momentum in terms of expanding its sales, even if it is currently struggling with profitability. Investors looking for companies that are at least growing their top line would find CNXC’s positive growth more appealing than ACLS’s contraction. The sheer scale of CNXC’s revenue also places it in a different league compared to ACLS’s $839,048,000, signifying a much larger market presence.

ACLS vs CNXC profitability

In terms of ACLS vs CNXC profitability, Axcelis Technologies (ACLS) demonstrates significantly stronger operational efficiency and net income generation. ACLS boasts a robust net margin of 11.93% and an EBITDA margin of 15.27%, reflecting its ability to translate revenue into profit. Its gross margin of 43.61% further highlights strong pricing power or cost control within its core operations. While its ROE is not available, the positive and substantial net margin indicates a healthy earnings capacity. Furthermore, ACLS maintains a very low Debt-to-Equity ratio of 0.04x, indicating a strong and financially stable balance sheet.

Concentrix Corporation (CNXC), on the other hand, is currently facing profitability challenges. It reported a negative net margin of -13.34% and a negative EBITDA margin of -9.49%. The gross margin stands at 32.81%, lower than ACLS, suggesting less efficiency in its cost of goods sold or pricing strategy. Despite its unprofitability, CNXC exhibits a remarkably high Free Cash Flow (FCF) yield of 31.2%, which could be a positive sign that while the company is not generating GAAP net income, it is still producing significant cash from its operations, possibly due to non-cash expenses like depreciation or amortization. Its Debt-to-Equity ratio of 1.7x is considerably higher than ACLS’s, indicating greater financial leverage.

Analyst ratings: ACLS vs CNXC

Analyst sentiment for ACLS vs CNXC provides an interesting perspective on future expectations. For Axcelis Technologies (ACLS), 12 analysts currently cover the stock, with 66.7% recommending a “Buy.” The consensus among these analysts is also “Buy.” However, their average price target for ACLS is $128, which implies a -19.3% downside from its current price of $158.66. This suggests that while analysts generally see value in the company, many believe the stock may be overvalued at its current level or anticipate a correction.

Concentrix Corporation (CNXC) garners a more enthusiastic outlook from analysts regarding potential upside. Out of 9 analysts, an impressive 77.8% recommend a “Buy,” also leading to an overall “Buy” consensus. Crucially, the average price target for CNXC is $52, representing a substantial +104.2% upside from its current price of $25.46. This strong positive target indicates that analysts see significant room for growth and recovery in CNXC’s stock price, aligning with the substantial DCF upside observed earlier, and making it the clear analyst favorite for future appreciation.

Should I buy ACLS or CNXC stock in 2026?

Deciding whether you should buy ACLS or CNXC stock in 2026 depends heavily on your investment strategy and risk tolerance. For growth investors, Concentrix Corporation (CNXC) appears to offer a more compelling narrative, despite its current unprofitability. Its positive revenue growth of 2.2% contrasts sharply with ACLS’s -17.6% decline. More significantly, CNXC’s massive DCF upside of +1287.4% and the high analyst target upside of +104.2% suggest a strong potential for future capital appreciation, assuming the company can execute a turnaround in its net profitability. ACLS, while profitable, is currently showing negative revenue momentum which might deter pure growth investors.

Value investors performing an ACLS vs CNXC fundamentals and valuation analysis would likely find CNXC to be the more attractive option. CNXC trades at a negative P/E and a P/B ratio of just 0.56x, indicating it might be significantly undervalued relative to its assets and potential future earnings. The staggering DCF upside of +1287.4% further reinforces a deep value proposition. In contrast, ACLS, with a P/E of 48.32x and a P/B of 4.67x, appears richly valued, especially given its negative revenue growth and negative DCF upside of -61.1%. While ACLS is profitable, its valuation metrics suggest limited upside from a value perspective at its current price.

For income-focused investors, neither stock stands out as a strong dividend play. ACLS currently offers a 0% dividend yield, while CNXC provides a minimal 0.06%. Therefore, if generating income is your primary objective, both ACLS and CNXC would be unsuitable choices. However, for investors seeking potential capital gains, CNXC’s significant analyst upside and DCF potential make it a noteworthy contender for 2026, provided one is comfortable with its current profitability challenges. This is not investment advice; please conduct your own thorough research before making any investment decisions.

More ACLS and CNXC comparisons

ACLS full stock analysis · CNXC full stock analysis · All stock comparisons

FAQ: ACLS vs CNXC